200HO10049 LOTTOMAX

Print/PDF
Registration Name ROCKYMOUNTAIN LOTTOMAX-ET
Registration Number HOCAN000011445882
Primary NAAB Code 200HO10049
Secondary Code(s)
Status Inactive
Controller Name Semex Alliance (200)
Date of Birth 10/26/2012
aAa 342516
DMS 126
GFI 10.2%
Genetic Codes * TR TP TV TL TY TD
Haplotypes HH1T, HH2T, HH3T, HH4T, HH5T, HH6T, HCD-T
Sire AMIGHETTI NUMERO UNO-ET
MGS CHARLESDALE SUPERSTITION-ET
Beta Casein -
Kappa Casein -
Beta Lactoglobulin -
INDEXES
NM$ 21, 93% R CM$ 11
NM Percentile 17% FM$ 46
GTPI 2479 GM$ 16
PRODUCTION TRAITS
2375 Dtrs 820 herds 38 % US 99% R
Milk -299 Fat, % 5 , +0.07%
SCS 2.93, 98% R Protein, % -17 , -0.03%
Feed Saved -68 , 66% R Milking Speed 7.25 , 81% R
Health & Fertility
Productive Life 1.8      97% R Mastitis -0.5      93% R
Heifer Livability -0.1       82% R Metritis 0.1      87% R
Livability 2.5      92% R D. Abom -0.2      91% R
DPR 1.4      98% R Ketosis -0.4      87% R
FSC 0.5      98% R R. Placenta 0.7      88% R
HCR -0.5      94% R Milk Fever -0.1      80% R
CCR 1.5      98% R
SCR -        -
DIA 0.2      59% R
RSP -0.8      75% R
Calving Traits
Sire CE 1.6      97% R 2776 Obs
Daughter CE 2.4      97% R 1139 Obs, 1064 Dtrs
Sire SB 4.8      95% R 2505 Obs
Daughter SB 5.4      95% R 1069 Obs, Dtrs
Gestation Length 1.6      99% R 214 Obs, 2240 Dtrs
Early First Calving -4.8      96% R 197 Obs, 806 Dtrs

CDCB August 2026; Base of Evaluation: HO

* Individual bull owners may test for more recessives

Composites HA 08/2026
1215 Dtrs 516 herds 98% R
PTA Type 0.69 UDC 0.42
HCC 0.83 BWC -0.43
FLC 0.35
Linear Traits
Stature 0.36
Tall
Strength -0.25
Strong
Body Depth 0.35
Deep
Dairy Form 0.69
Open
Rump Angle 0.13
Sloped
Thurl Width -0.22
Sloped
Rear Legs-Side View -0.22
Narrow
Rear Legs-Rear View -0.61
H.-in
Foot Angle 0.20
Steep
Feet & Legs Score 0.76
High
F.U. Attachment 1.41
Curved
Rear Udder Height 0.76
High
Rear Udder Width -0.01
Narrow
Udder Cleft 2.67
Strong
Udder Depth -0.61
H.-in
Front Teat Placement 1.30
Close
Rear Teat Placement 2.24
Close
Teat Length 1.30
Long
-2
0
2

CDCB August 2026; Base of Evaluation: HO